Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2015 1
2016 4
2017 2
2019 1
2022 2
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
[Investigation of familial tendency of endometriosis].
Zhang JJ, Guo HY, Shang CL, Liu L, Huang CY, Wu ZX, Li Y, Wu Y, Li HJ, Liang HM, Xu B. Zhang JJ, et al. Among authors: shang cl. Zhonghua Fu Chan Ke Za Zhi. 2023 Jul 25;58(7):501-507. doi: 10.3760/cma.j.cn112141-20221222-00768. Zhonghua Fu Chan Ke Za Zhi. 2023. PMID: 37474323 Chinese.
Reducing Target Volumes of Intensity Modulated Radiation Therapy After Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Long-Term Results of a Prospective, Multicenter, Randomized Trial.
Xiang L, Rong JF, Xin-Chen, Li XY, Zheng Y, Ren PR, Lin S, Wen QL, He LJ, Zhang JW, Shang CL, Yang HR, Fan J, Pang HW, Zhang J, Tan BX, Zhang L, Du XB, Wen SM, Jiang L, Qin G, Wu JB. Xiang L, et al. Among authors: shang cl. Int J Radiat Oncol Biol Phys. 2023 Nov 15;117(4):914-924. doi: 10.1016/j.ijrobp.2023.06.001. Epub 2023 Jun 24. Int J Radiat Oncol Biol Phys. 2023. PMID: 37356553 Clinical Trial.
Effect of 3-Dimensional Interstitial High-Dose-Rate Brachytherapy With Regional Metastatic Lymph Node Intensity-Modulated Radiation Therapy in Locally Advanced Peripheral Non-Small Cell Lung Cancer: 5-Year Follow-up of a Phase 2 Clinical Trial.
Xiang L, Ren PR, Li HX, Ye H, Pang HW, Wen QL, Zhang JW, He LH, Shang CL, Yang BY, Lin SL, Wu JW. Xiang L, et al. Among authors: shang cl. Int J Radiat Oncol Biol Phys. 2023 Feb 1;115(2):347-355. doi: 10.1016/j.ijrobp.2022.07.028. Epub 2022 Jul 25. Int J Radiat Oncol Biol Phys. 2023. PMID: 35901979 Clinical Trial.
Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
Liu TY, Chen J, Shang CL, Shen HW, Huang JM, Liang YC, Wang W, Zhao YH, Liu D, Shu M, Guo LY, Hu Z, Yao SZ. Liu TY, et al. Among authors: shang cl. J Exp Clin Cancer Res. 2016 Oct 28;35(1):170. doi: 10.1186/s13046-016-0445-5. J Exp Clin Cancer Res. 2016. PMID: 27793172 Free PMC article.
14 results